Jordanian healthtech startup Carevision, founded by Amani Abulaban, has secured a new investment from 2080 Ventures. The funding comes through the Jordan x 2080 Accelerator and will support the company’s mission to make AI-powered cardiometabolic screening accessible through a simple 60-second smartphone scan.
Quick Facts
- Startup: Jordanian AI healthtech Carevision
- Funding: Investment from 2080 Ventures
- Technology: 60-second smartphone cardiometabolic risk scanner
Accelerator Momentum for a Growing Ecosystem
The investment marks the second Jordanian company backed by 2080 Ventures through its dedicated accelerator program, following its initial investment in Bridge, a digital infrastructure provider for the pharmaceutical sector. Carevision’s funding announcement comes on the heels of its completion of the 500 Global | Sanabil Investments Accelerator, signaling strong momentum for the early-stage company.
Both Carevision and Bridge officially opened their seed rounds after participating in the accelerator’s Demo Day in Amman on December 15th. According to 2080 Ventures, it played a key role in structuring the rounds and contributed capital as an anchor investor alongside other MENA and US-based co-investors. Both seed rounds currently remain open for additional investors to join before closing.
A Strategic Partnership-Driven Approach
The successful entry of 2080 Ventures into Jordan highlights a deepening focus on the country’s startup ecosystem. This move was supported by a strategic collaboration with Jordan’s Ministry of Digital Economy & Entrepreneurship (MoDEE), which has been integral to establishing the Jordan x 2080 Accelerator.
In her announcement, founder Amani Abulaban acknowledged the Ministry’s support “for its continued commitment to strengthening startup ecosystem and creating pathways for founders to connect with global investors and scale internationally.”
About Carevision
Founded in 2024, Carevision is a technology company focused on transforming preventative healthcare. Its mission is to make screening accessible to everyone by building the infrastructure for preventive wellness at scale. The company’s technology allows individuals to use their smartphones for early detection of cardiometabolic health risks, empowering them to take control of their health before conditions escalate.
About 2080 Ventures
2080 Ventures is a venture capital accelerator focused on emerging markets. It provides startup acceleration tailored to local markets, leveraging its managing partners’ backgrounds at global accelerators like Techstars and 500 Global. The partners have experience with multiple startup exits and have invested in three unicorns, including Animoca Brands, SpaceX, and Cerebras.
Source: LinkedIn
